Last reviewed · How we verify

NCT05921461

The Use of HOVR Technology for Assessment of Blood Associated Parameters

Completed Last updated 27 June 2023
What this trial tests

trial in Peripheral Arterial Disease in 60 participants. Completed in 16 March 2023.

Timeline
1 May 2022
Primary endpoint
16 March 2023
16 March 2023

Quick facts

Lead sponsorVotis Subdermal Imaging Technologies LTD
StatusCompleted
Study typeOBSERVATIONAL
Enrollment60
Start date1 May 2022
Primary completion16 March 2023
Estimated completion16 March 2023
Sites1 location across Israel

Conditions studied

Sponsor

Votis Subdermal Imaging Technologies LTD

Who can join

40 and older, any sex, with Peripheral Arterial Disease or Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Feasibility, usability and safety clinical study that is aimed at testing of the non-invasive VOTIS PedCheck system for measurement of changes in absorption of light in order to derive changes in perfusion and oxygen levels in the foot.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Peripheral Arterial Disease

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05921461.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing